<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Accurate diagnosis of <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> in patients with <z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo> is critical for clinical decision-making and patient management </plain></SENT>
<SENT sid="1" pm="."><plain>IMP3 is an oncofetal protein and has been demonstrated to be associated with aggressive <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> behavior </plain></SENT>
<SENT sid="2" pm="."><plain>The aim of this study was to establish the expression pattern and diagnostic value of IMP3 in <z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo>, <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, and <z:mp ids='MP_0002038'>carcinoma</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>A total of 217 cases (resection, n=56; biopsy, n=161) with 302 lesions (invasive esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp>, n=147; metastatic esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp>, n=14; high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> of the esophagus, n=52; low-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> of the esophagus gland, n=21; and <z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo>, n=68) were examined by immunohistochemistry for IMP3 expression </plain></SENT>
<SENT sid="4" pm="."><plain>IMP3 showed strong cytoplasmic granular staining in 138 of 147 (94%) of invasive esophageal <z:mp ids='MP_0009308'>adenocarcinomas</z:mp>, 13 of 14 (93%) of metastatic esophageal <z:mp ids='MP_0009308'>adenocarcinomas</z:mp>, and 49 of 52 (94%) of high-grade <z:mpath ids='MPATH_589'>dysplasias</z:mpath> </plain></SENT>
<SENT sid="5" pm="."><plain>In contrast, 3/21 (14%) of low-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and 5/68 (7%) <z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo> were positive for IMP3 </plain></SENT>
<SENT sid="6" pm="."><plain>Expression of IMP3 was not found in adjacent benign squamous and glandular mucosa </plain></SENT>
<SENT sid="7" pm="."><plain>Our findings indicate that IMP3 is a highly sensitive and specific biomarker for the diagnosis of invasive esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> and high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> </plain></SENT>
<SENT sid="8" pm="."><plain>The data also suggest that IMP3, an oncofetal protein, may play an important role in <z:e sem="disease" ids="C1608408" disease_type="Neoplastic Process" abbrv="">malignant transformation</z:e> in esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
</text></document>